Literature DB >> 27567055

NICE guidance on ramucirumab for previously treated locally advanced or metastatic non-small-cell lung cancer.

Caroline J Hall1, Nwamaka Umeweni2, Helen Knight2, Lindsay Smith2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27567055     DOI： 10.1016/S1470-2045(16)30435-1

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  1 in total

1.  Pre-Existing Diabetes Limits Survival Rate After Immune Checkpoint Inhibitor Treatment for Advanced Lung Cancer: A Retrospective Study in Japan.

Authors:  Kaori Hisanaga; Hiroshi Uchino; Naoko Kakisu; Masahiko Miyagi; Fukumi Yoshikawa; Genki Sato; Kazutoshi Isobe; Kazuma Kishi; Sakae Homma; Takahisa Hirose
Journal:  Diabetes Metab Syndr Obes       Date:  2021-02-22       Impact factor: 3.168
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.